Scott Leftwich, Director at Calidi Biotherapeutics, Inc. (CLDI), bought 125,000 shares at $2.00 ($250K) on 2025-08-21, disclosed to the SEC on 2025-08-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.